MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma
Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) treatment failure is a rigorous problem in patients with diffuse large B-cell lymphoma (DLBCL), which usually predicts poor survival. The study explored the association of microRNAs with R-CHOP res...
Main Authors: | Haibo Huang, Junjiao Gu, Shuna Yao, Zhihua Yao, Yan Zhao, Qingxin Xia, Jie Ma, Ling Mai, Shujun Yang, Yanyan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Cancer Translational Medicine |
Subjects: | |
Online Access: | http://www.cancertm.com/article.asp?issn=2395-3977;year=2015;volume=1;issue=1;spage=6;epage=10;aulast=Huang |
Similar Items
-
Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
by: Myrna Candelaria, et al.
Published: (2021-01-01) -
Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab
by: Agustin Aviles, et al.
Published: (2019-09-01) -
Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
by: Song G, et al.
Published: (2016-06-01) -
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma
by: Patrick B. Johnston, et al.
Published: (2021-02-01) -
A clinicopathologic study of mantle cell lymphoma in a single center study in India
by: Gujral S, et al.
Published: (2008-07-01)